Atlas Trials

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects

Clinical trial NCT07703982 · COMPLETED

Trial details

NCT number
NCT07703982
Sponsor
Aquestive Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergic Reaction
Start date
2024-12-26
Primary completion
2025-03-14
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.